Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Hayes

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
JAMA|August 6, 1982
Advances in cardiovascular pharmacologyA H Hayes
Journal of Clinical Pharmacology|April 1, 1975
Role of the clinical pharmacologist in teaching therapeuticsA H Hayes
Rational Drug Therapy|July 1, 1972
The actions and clinical use of the newer antiarrhythmic drugsA H Hayes
Clinical Pharmacology and Therapeutics|July 1, 1974
Pharmacodynamic and pharmacokinetic measurements in cardiovascular-renal drugsA H Hayes
Drug Safety|January 1, 1990
Safety considerations in product developmentA H Hayes
U. S. Medicine|December 26, 1982
FDA reforms drug approval systemA H Hayes
Medical Marketing & Media|January 11, 1983
The Commissioner looks back at Tylenol and ahead to improved proceduresA H Hayes
Pharmacy Times|October 8, 1981
How the FDA looks ahead while celebrating its 75th anniversaryA H Hayes
Medical Economics|July 18, 1982
A fresh--and friendlier--wind blows from the FDA. Interview by John H. LavinA H Hayes
Hospital Formulary|July 10, 1982
The latest word from the FDA: an exclusive interview with the commissioner. Interview by John A. Owen JrA H Hayes
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
JAMA|August 6, 1982
Advances in cardiovascular pharmacologyA H Hayes
Journal of Clinical Pharmacology|April 1, 1975
Role of the clinical pharmacologist in teaching therapeuticsA H Hayes
Rational Drug Therapy|July 1, 1972
The actions and clinical use of the newer antiarrhythmic drugsA H Hayes
Clinical Pharmacology and Therapeutics|July 1, 1974
Pharmacodynamic and pharmacokinetic measurements in cardiovascular-renal drugsA H Hayes
Drug Safety|January 1, 1990
Safety considerations in product developmentA H Hayes
U. S. Medicine|December 26, 1982
FDA reforms drug approval systemA H Hayes
Medical Marketing & Media|January 11, 1983
The Commissioner looks back at Tylenol and ahead to improved proceduresA H Hayes
Pharmacy Times|October 8, 1981
How the FDA looks ahead while celebrating its 75th anniversaryA H Hayes
Medical Economics|July 18, 1982
A fresh--and friendlier--wind blows from the FDA. Interview by John H. LavinA H Hayes
Hospital Formulary|July 10, 1982
The latest word from the FDA: an exclusive interview with the commissioner. Interview by John A. Owen JrA H Hayes
Pageof 6